Corning Inc · GLW · FY2026 Q2 · Calendar Q3 2026
Corning Q2: AI optics momentum strengthens the Springboard plan
The Q2 evidence supports the view that resilient AI-linked demand can sustain Corning’s growth trajectory: optical communications and enterprise AI sales accelerated, while multi-year agreements and the Springboard plan strengthen visibility. The counterweight is execution risk around scale-up, photonics timing, solar profitability and cyclical end markets.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about GLW FY2026 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, the narrative shifted from securing major agreements and preparing solar capacity to demonstrating stronger optical and enterprise AI momentum. Management also provided a more developed photonics and Springboard scale-up framework, while the solar facility upgrade set up a post-shutdown ramp.
Guidance delta
Management guidance sentiment was maintained; Q2 results exceeded guidance. The call emphasized continued margin expansion and free-cash-flow growth.
Key takeaways
- Q2 sales reached $4.74 billion and EPS was $0.78, with both above the supplied estimates.
- Optical Communications grew 32%, while enterprise AI-related sales rose 65%.
- Management reiterated the Springboard path toward $20B, $30B and $40B annualized sales run rates.
- Multi-year agreements with Apple, Meta, NVIDIA and Amazon support the long-term demand case.
- Solar capacity upgrades are intended to support a $3B revenue goal and improved profitability.
Management priorities
- Scale optical connectivity for AI data centers.
- Develop the passive-photonics platform, including co-packaged optics.
- Expand Gen AI fiber sales and fiber content per GPU.
- Ramp upgraded solar-wafer capacity after the maintenance shutdown.
- Provide more detailed Springboard milestones.
Follow GLW with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 24, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Mizuho | Outperform | Outperform | Maintain | Sep 15, 2026 |
| Truist Securities | Buy | Hold | Upgrade | Aug 3, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 29, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 29, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 29, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 29, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 29, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 6, 2026 |
| UBS | Buy | Buy | Maintain | Jun 5, 2026 |
| Susquehanna | Positive | Positive | Maintain | Apr 29, 2026 |
| Argus Research | Buy | Buy | Maintain | Oct 29, 2025 |
| HSBC | Buy | Hold | Upgrade | Jan 30, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Oct 30, 2024 |
| Fox Advisors | Overweight | Equal Weight | Upgrade | Jun 17, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 26, 2023 |
| Goldman Sachs | Buy | Neutral | Upgrade | Jan 27, 2022 |
| Cross Research | Neutral | Buy | Downgrade | Sep 17, 2019 |
| Bank of America | Buy | Neutral | Upgrade | May 1, 2019 |
| Bernstein | Market Perform | Outperform | Downgrade | Feb 1, 2017 |
| Guggenheim | Buy | Buy | Maintain | Jan 4, 2017 |
| Wells Fargo | Perform | Market Perform | Maintain | Dec 21, 2016 |
| Standpoint Research | Hold | Buy | Downgrade | Jun 13, 2016 |
| Drexel Hamilton | Sell | Buy | Downgrade | Jun 10, 2016 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Sep 28, 2015 |
| Benchmark | Hold | Hold | Maintain | Jul 29, 2015 |
| RBC Capital | Outperform | Sector Perform | Upgrade | Jun 16, 2015 |
| CLSA | Sell | Underperform | Maintain | Apr 29, 2015 |
| Jefferies | Hold | Hold | Maintain | Feb 2, 2015 |
| Standpoint | Buy | Hold | Upgrade | Oct 15, 2014 |
| Stifel Nicolaus | Buy | Buy | Maintain | Oct 23, 2013 |
| Stifel | Buy | Buy | Maintain | Oct 23, 2013 |
| Sterne Agee | Neutral | Buy | Downgrade | Oct 23, 2013 |
| PiperJaffray | Neutral | Overweight | Downgrade | Oct 11, 2013 |
| Piper Sandler | Neutral | Overweight | Downgrade | Oct 11, 2013 |
| Gilford Securities | Buy | Buy | Maintain | Sep 23, 2013 |
| Cantor Fitzgerald | Hold | Hold | Maintain | Sep 19, 2013 |
| Topeka | Buy | Buy | Maintain | Nov 27, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $154.48. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | John Roberts | $180 | $143.5 | +16.5% | Sep 15, 2026 |
| Truist Financial | Analyst unavailable | $175 | $138.25 | +13.3% | Aug 2, 2026 |
| Morgan Stanley | Analyst unavailable | $165 | $125.88 | +6.8% | Jul 29, 2026 |
| Mizuho Securities | Analyst unavailable | $210 | $125.88 | +35.9% | Jul 29, 2026 |
| UBS | Joshua Spector | $196 | $125.88 | +26.9% | Jul 29, 2026 |
| Oppenheimer | Analyst unavailable | $200 | $125.88 | +29.5% | Jul 29, 2026 |
| Barclays | Tim Long | $129 | $125.88 | -16.5% | Jul 29, 2026 |
| Oppenheimer | Martin Yang | $230 | $194.77 | +48.9% | Jul 7, 2026 |
| UBS | Analyst unavailable | $243 | $196.7 | +57.3% | Jul 6, 2026 |
| Mizuho Securities | John Roberts | $270 | $255.54 | +74.8% | Jul 1, 2026 |
| Truist Financial | Matthew Niknam | $205 | $195 | +32.7% | Jun 22, 2026 |
| UBS | Joshua Spector | $228 | $197.93 | +47.6% | Jun 5, 2026 |
| Mizuho Securities | Analyst unavailable | $220 | $207.3 | +42.4% | May 12, 2026 |
| Morgan Stanley | Meta Marshall | $180 | $192.7 | +16.5% | May 8, 2026 |
| Barclays | Tim Long | $180 | $182.42 | +16.5% | May 8, 2026 |
| UBS | Analyst unavailable | $223 | $181.57 | +44.4% | May 7, 2026 |
| Truist Financial | Analyst unavailable | $149 | $149.3 | -3.5% | Apr 29, 2026 |
| Susquehanna | Analyst unavailable | $180 | $153.05 | +16.5% | Apr 29, 2026 |
| Barclays | Tim Long | $149 | $153.05 | -3.5% | Apr 29, 2026 |
| Morgan Stanley | Meta Marshall | $140 | $164.37 | -9.4% | Apr 20, 2026 |
| Mizuho Securities | Analyst unavailable | $160 | $165.1 | +3.6% | Apr 8, 2026 |
| Morgan Stanley | Analyst unavailable | $127 | $139.51 | -17.8% | Feb 23, 2026 |
| Mizuho Securities | Analyst unavailable | $145 | $139.51 | -6.1% | Feb 23, 2026 |
| HSBC | Stephen Bersey | $135 | $131.5 | -12.6% | Feb 13, 2026 |
| UBS | Joshua Spector | $125 | $105.58 | -19.1% | Jan 30, 2026 |
| Morgan Stanley | Analyst unavailable | $103 | $100.86 | -33.3% | Jan 29, 2026 |
| Oppenheimer | Analyst unavailable | $120 | $102.76 | -22.3% | Jan 29, 2026 |
| Susquehanna | Analyst unavailable | $125 | $104.29 | -19.1% | Jan 29, 2026 |
| Mizuho Securities | Analyst unavailable | $120 | $104.29 | -22.3% | Jan 29, 2026 |
| Barclays | Analyst unavailable | $100 | $104.29 | -35.3% | Jan 29, 2026 |
| Wolfe Research | George Notter | $130 | $110.98 | -15.8% | Jan 27, 2026 |
| Morgan Stanley | Meta Marshall | $98 | $86.29 | -36.6% | Dec 17, 2025 |
| UBS | Analyst unavailable | $109 | $78.03 | -29.4% | Nov 21, 2025 |
| Argus Research | Analyst unavailable | $110 | $91.56 | -28.8% | Oct 29, 2025 |
| UBS | Analyst unavailable | $100 | $87.5 | -35.3% | Oct 29, 2025 |
| Morgan Stanley | Analyst unavailable | $82 | $87.5 | -46.9% | Oct 29, 2025 |
| Mizuho Securities | Analyst unavailable | $97 | $86.43 | -37.2% | Oct 29, 2025 |
| Oppenheimer | Analyst unavailable | $100 | $87.5 | -35.3% | Oct 29, 2025 |
| Susquehanna | Analyst unavailable | $100 | $90.01 | -35.3% | Oct 29, 2025 |
| Barclays | Analyst unavailable | $83 | $86.43 | -46.3% | Oct 29, 2025 |
| Morgan Stanley | Analyst unavailable | $75 | $87.19 | -51.5% | Oct 10, 2025 |
| Mizuho Securities | Analyst unavailable | $90 | $82.52 | -41.7% | Oct 3, 2025 |
| UBS | Joshua Spector | $91 | $79.16 | -41.1% | Sep 23, 2025 |
| UBS | Analyst unavailable | $84 | $68.47 | -45.6% | Sep 2, 2025 |
| Mizuho Securities | John Roberts | $74 | $65.77 | -52.1% | Aug 8, 2025 |
| Morgan Stanley | Analyst unavailable | $56 | $62.61 | -63.7% | Jul 30, 2025 |
| Oppenheimer | Analyst unavailable | $72 | $62.61 | -53.4% | Jul 30, 2025 |
| Susquehanna | Analyst unavailable | $75 | $62.61 | -51.5% | Jul 30, 2025 |
| Mizuho Securities | John Roberts | $59 | $53.04 | -61.8% | Jul 15, 2025 |
| Mizuho Securities | John Roberts | $52 | $42 | -66.3% | Apr 15, 2025 |
| HSBC | Stephen Bersey | $60 | $49.8 | -61.2% | Jan 30, 2025 |
| Oppenheimer | Martin Yang | $58 | $48.84 | -62.5% | Oct 30, 2024 |
| Deutsche Bank | Matt Niknam | $54 | $49.03 | -65.0% | Oct 30, 2024 |
| Barclays | Tim Long | $53 | $49.03 | -65.7% | Oct 29, 2024 |
| Bank of America Securities | Wamsi Mohan | $56 | $49.03 | -63.7% | Oct 29, 2024 |
| Deutsche Bank | Matt Niknam | $49 | $45.66 | -68.3% | Oct 9, 2024 |
| Mizuho Securities | John Roberts | $51 | $44.65 | -67.0% | Sep 24, 2024 |
| Bank of America Securities | Wamsi Mohan | $51 | $44.3 | -67.0% | Sep 20, 2024 |
| Susquehanna | Mehdi Hosseini | $55 | $44.33 | -64.4% | Sep 20, 2024 |
| Oppenheimer | Martin Yang | $51 | $44.43 | -67.0% | Sep 20, 2024 |
| Citigroup | Asiya Merchant | $50 | $41.37 | -67.6% | Sep 6, 2024 |
| Mizuho Securities | John Roberts | $47 | $40.73 | -69.6% | Aug 21, 2024 |
| Bank of America Securities | Wamsi Mohan | $46 | $39.74 | -70.2% | Jul 31, 2024 |
| Deutsche Bank | Matt Niknam | $46 | $39.74 | -70.2% | Jul 31, 2024 |
| Morgan Stanley | Meta Marshall | $39 | $42.9 | -74.8% | Jul 26, 2024 |
| Argus Research | Jim Kelleher | $50 | $43.05 | -67.6% | Jul 9, 2024 |
| Mizuho Securities | John Roberts | $42 | $38.75 | -72.8% | Jun 18, 2024 |
| US Capital Advisors | Steve Fox | $45 | $37.25 | -70.9% | Jun 17, 2024 |
| Morgan Stanley | Meta Marshall | $38 | $38.02 | -75.4% | Jun 13, 2024 |
| UBS | Joshua Spector | $38 | $35.55 | -75.4% | May 30, 2024 |
| Mizuho Securities | John Roberts | $36 | $33.44 | -76.7% | May 7, 2024 |
| Susquehanna | Analyst unavailable | $40 | $35.68 | -74.1% | Feb 2, 2023 |
| Susquehanna | Mehdi Hosseini | $50 | $42.12 | -67.6% | Jan 30, 2022 |
| Barclays | Tim Long | $52 | $40.56 | -66.3% | Jan 27, 2022 |
| Oppenheimer | Martin Yang | $48 | $34.93 | -68.9% | Oct 27, 2021 |
Track every rating change on GLW the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCorning Incorporated operates in optical communications, display, specialty materials, automotive, and life sciences businesses in the United States, Canada, Mexico, Japan, Taiwan, China, South Korea, Germany, and internationally. The company provides optical fibers and cables; and hardware and equipment products, such as cable assemblies, fiber optic hardware and connectors, optical components and couplers, closures, network interface devices, and other accessories for the telecommunications industry, businesses, governments, and individuals. It also offers glass substrates for flat panel displays, including liquid crystal displays and organic light-emitting diodes that are used in televisions, notebook computers, desktop monitors, tablets, and handheld devices.…
Historical context
All GLW earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ADBE Adobe Inc. | FY2026 Q3 · Calendar Q3 2026 | +0.8% | +1.4% | Adobe raises FY26 outlook as AI strategy broadens |
| ORCL Oracle Corporation | FY2027 Q1 · Calendar Q3 2026 | +10.3% | -1.7% | Oracle raises FY27 outlook as AI demand accelerates cloud growth |
| SAIL SailPoint, Inc. | FY2027 Q2 · Calendar Q3 2026 | +13.8% | -1.2% | SailPoint pairs 25% ARR growth with accelerating AI-driven adoption |
| CIEN Ciena Corporation | FY2026 Q3 · Calendar Q3 2026 | +22.0% | -10.4% | Ciena raises outlook as AI networking demand lifts backlog |
| DOCU DocuSign, Inc. | FY2027 Q2 · Calendar Q3 2026 | +6.4% | +3.7% | DocuSign Q2 FY27: IAM momentum supports a raised outlook |
| IOT Samsara Inc. | FY2027 Q2 · Calendar Q3 2026 | +25.0% | +3.7% | Samsara: AI adoption expands as FY27 guidance holds |
Latest beats and misses
Who reports nextBeat on EPS
- AZOFY2026 Q4 · September 22, 2026+3.6% EPS+3.3% move
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
Get the GLW recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-07-28T16:05:48.847958+00:00
- FN2 earnings calendar · 2026-09-02T01:23:14.593608+00:00
- Polygon adjusted daily market bars · 2026-09-24T01:00:54.759175+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-24T01:00:54.756285+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-24. For educational purposes only; not investment advice.